Muutke küpsiste eelistusi

E-raamat: Superbugs: An Arms Race against Bacteria

  • Formaat: EPUB+DRM
  • Ilmumisaeg: 09-Apr-2018
  • Kirjastus: Harvard University Press
  • Keel: eng
  • ISBN-13: 9780674985070
  • Formaat - EPUB+DRM
  • Hind: 35,04 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 09-Apr-2018
  • Kirjastus: Harvard University Press
  • Keel: eng
  • ISBN-13: 9780674985070

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Antibiotics are powerful drugs that can prevent and treat infections, but they are becoming less effective as a result of drug resistance. Resistance develops because the bacteria that antibiotics target can evolve ways to defend themselves against these drugs. When antibiotics fail, there is very little else to prevent an infection from spreading.

Unnecessary use of antibiotics in both humans and animals accelerates the evolution of drug-resistant bacteria, with potentially catastrophic personal and global consequences. Our best defenses against infectious disease could cease to work, surgical procedures would become deadly, and we might return to a world where even small cuts are life-threatening. The problem of drug resistance already kills over one million people across the world every year and has huge economic costs. Without action, this problem will become significantly worse.

Following from their work on the Review on Antimicrobial Resistance, William Hall, Anthony McDonnell, and Jim O’Neill outline the major systematic failures that have led to this growing crisis. They also provide a set of solutions to tackle these global issues that governments, industry, and public health specialists can adopt. In addition to personal behavioral modifications, such as better handwashing regimens, Superbugs argues for mounting an offense against this threat through agricultural policy changes, an industrial research stimulus, and other broad-scale economic and social incentives.



Antibiotics are powerful drugs that can prevent and treat infections, but they are becoming less effective as a result of drug resistance. Superbugs describes this growing global threat, the systematic failures that have led to it, and solutions that governments, industries, and public health specialists can adopt.

Arvustused

[ L]ucid and thoughtful Superbugs provides a set of policy prescriptions, framed in pragmatic terms meant to motivate self-interested politicians. -- Jerome Groopman * New York Review of Books * An immensely readable description of the challenges that encourage overuse of antibiotics and discourage new drug developmentSuperbugs is a worthy exposition of the challenges we will have to surmount to incentivize more responsible antibiotic use until we discover new ways of dealing with infections. -- Ramanan Laxminarayan * Science * As antibiotics become increasingly ineffective, modern medicine faces a global threat. Can we do anything to stop it? Thats the question posed by the book Superbugs: An Arms Race against Bacteria. [ The] authors look at the rise of drug resistance, and their research is sobering. * Late Night Live (Australian Broadcasting Corporation) * Excellent. * Choice * Jim ONeill helped take the issue of antimicrobial resistance from the science lab to the global stage. He and coauthors Anthony McDonnell and William Hall impart a compelling story about the battle against what could become a mass killer of humanity. -- David Cameron, former Prime Minister of the United Kingdom Addressing antimicrobial resistance requires the kind of thoughtful yet action-oriented analysis that this vitally important book provides. The messages in Superbugs should be heeded by individuals, government officials, and policymakers around the world. -- Larry Summers, former director of the White House National Economic Council With superb insight into one of the greatest health threats to humankind, Superbugs highlights the need for an integrated, multifaceted approach to treating drug-resistant infections. This riveting book makes a compelling case for action. -- Peter Piot, London School of Hygiene and Tropical Medicine

Foreword vii
Sally Davies
Introduction 1(8)
Part I The Problem of Drug Resistance
Chapter 1 When a Scratch Could Kill
9(21)
Chapter 2 The Rise of Resistance
30(24)
Chapter 3 Failures in Tackling Drug-Resistant Infections
54(31)
Part II Solutions to Counter Antimicrobial Resistance
Chapter 4 Incentives for New Drug Development
85(31)
Chapter 5 Prevention Is Better than Cure
116(29)
Chapter 6 Reducing Unnecessary Use of Antibiotics in Humans
145(22)
Chapter 7 Agriculture and the Environment
167(26)
Chapter 8 Next Steps
193(24)
Notes 217(4)
Bibliography 221(14)
Acknowledgments 235(4)
Index 239
William Hall, a public policy professional, served as Senior Policy Advisor for the Review on Antimicrobial Resistance. Anthony McDonnell is Senior Health Economist, Nuffield Department of Medicine, University of Oxford, and was Head of Economic Research for the Review on Antimicrobial Resistance. Jim ONeill, an internationally recognized economist, served as Chair of the Review on Antimicrobial Resistance.